ribociclib
novartis
[' ribo', 'breast', 'ribociclib', 'bcsm']
adding ribociclib to endocrine therapy may reduce recurrence risk in patients with hormone receptor positive, her2-negative early-stage breast cancer #bcsm #breastcancer #oncology #asco23
News and views from the world of clinical oncology and hematology